Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran

被引:51
|
作者
Sepehr, A
Tanière, P
Martel-Planche, G
Zia'ee, AA
Rastgar-Jazii, F
Yazdanbod, M
Etemad-Moghadam, G
Kamangar, F
Saidi, F
Hainaut, P
机构
[1] IARC, Grp Mol Carcinogenesis, F-69008 Lyon, France
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
[3] NRCGEB, Tehran, Iran
[4] Univ Tehran Med Sci, Dept Surg, Tehran, Iran
[5] Iran Mehr Hosp, Dept Pathol, Tehran, Iran
[6] Iran Mehr Hosp, Dept Surg, Tehran, Iran
[7] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
关键词
esophagus; neoplasms; Iran; p53; COX-2;
D O I
10.1038/sj.onc.1204912
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extremely high rates of squamous cell carcinoma of the esophagus (SCCE), are observed in Iran,, reflecting unknown, genetic and/or epidemiological risk factors. Among genetic alterations, in SCCE,: TP53: mutations are the most frequent, vary among populations, and may provide clues on etiological mechanisms. We have analysed mutations in TP53 (exons 5-8): in 98 SCCE from Iran by temporal temperature get electrophoresis and direct sequencing. We found 58, mutations, in 49 patients, (50%,), with a high prevalence of C to T transitions at CpG dinucleotides (29.3%). The TP53 mutation pattern in Iran was significantly different from that observed in SCCEs from high incidence areas of China and Western Europe (P=0.007)., Moreover, the prevalence of mutations at A:T base pairs, (transitions and transversions) was higher in men than in women (38.7%, vs 11.1%, P=0.033). COX-2 overexpression was, detected in 69% of the cases evaluated (24/35), without significant association with TP53, mutation. Accumulation of nitrotyrosine, a marker of protein damage by excess, levels of nitric oxide, was observed in tumor cells, in six of 16 cases analysed. These results are consistent with the hypothesis that several factors are involved in TP53 mutagenesis, in Iran., These factors include a baseline of chronic inflammatory stress, which may have a multiplicative impact on the sensitivity of esophageal cells to exogenous factors of risk.
引用
收藏
页码:7368 / 7374
页数:7
相关论文
共 50 条
  • [21] Specific TP53 mutations predict aggressive phenotype in head and neck squamous cell carcinoma: a retrospective archival study
    Peltonen, Jenni K.
    Vahakangas, Kirsi H.
    Helppi, Henni M.
    Bloigu, Risto
    Paakko, Paavo
    Turpeenniemi-Hujanen, Taina
    HEAD & NECK ONCOLOGY, 2011, 3
  • [22] Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus
    Lacerda, C. F.
    Cruvinel-Carloni, A.
    Torres de Oliveira, A. T.
    Scapulatempo-Neto, C.
    Lopez, R. V. M.
    Crema, E.
    Adad, S. J.
    Rodrigues, M. A. M.
    Henry, M. A. C. A.
    Guimaraes, D. P.
    Reis, R. M.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (04) : 1 - 9
  • [23] Predicting survival in head and neck squamous cell carcinoma from TP53 mutation
    Masica, David L.
    Li, Shuli
    Douville, Christopher
    Manola, Judith
    Ferris, Robert L.
    Burtness, Barbara
    Forastiere, Arlene A.
    Koch, Wayne M.
    Chung, Christine H.
    Karchin, Rachel
    HUMAN GENETICS, 2015, 134 (05) : 497 - 507
  • [24] TP53 codon 72 polymorphism and risk of conjunctival squamous cell carcinoma in Uganda
    Tornesello, ML
    Waddell, KM
    Duraturo, ML
    Biryahwaho, B
    Downing, R
    Lucas, SB
    Giani, U
    Buonaguro, L
    Buonaguro, FM
    CANCER DETECTION AND PREVENTION, 2005, 29 (06): : 501 - 508
  • [25] TP53 Germline Mutations in Adult Patients with Adrenocortical Carcinoma
    Herrmann, Leonie J. M.
    Heinze, Britta
    Fassnacht, Martin
    Willenberg, Holger S.
    Quinkler, Marcus
    Reisch, Nicole
    Zink, Martina
    Allolio, Bruno
    Hahner, Stefanie
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (03) : E476 - E485
  • [26] Mutations of TSHR and TP53 Genes in an Aggressive Clear Cell Follicular Carcinoma of the Thyroid
    Tong, Guo-Xia
    Mody, Kokila
    Wang, Zhuo
    Hamele-Bena, Diane
    Nikiforova, Marina N.
    Nikiforov, Yuri E.
    ENDOCRINE PATHOLOGY, 2015, 26 (04) : 315 - 319
  • [27] Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma
    Gleber-Netto, Frederico O.
    Neskey, David
    de Mattos Costa, Ana Flavia
    Kataria, Pranav
    Rao, Xiayu
    Wang, Jing
    Kowalski, Luiz Paulo
    Pickering, Curtis R.
    Dias-Neto, Emmanuel
    Myers, Jeffrey N.
    CANCER, 2020, 126 (20) : 4498 - 4510
  • [28] THE LACK OF CORRELATION BETWEEN TP53 MUTATIONS AND GASTRIC CANCER: A REPORT FROM A PROVINCE OF IRAN
    Saffari-Chaleshtori, Javad
    Tabatabaiefar, Mohammad-Amin
    Ghasemi-Dehkordi, Payam
    Farokhi, Effat
    Moradi, Mohammad-Taghi
    Hashemzadeh-Chaleshtori, Morteza
    GENETIKA-BELGRADE, 2017, 49 (01): : 235 - 246
  • [29] Are TP53 mutations all alike?
    Wong, Terrence N.
    Link, Daniel C.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2024, (01) : 321 - 325
  • [30] TP53 mutations in myelodysplastic syndrome
    Misawa, S
    Horiike, S
    LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 417 - 422